Actively Recruiting
PeptiCol EZgraft in the Extraction Socket Preservation Process After Tooth Extraction
Led by NIBEC Co., Ltd. · Updated on 2025-10-03
114
Participants Needed
1
Research Sites
59 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial aims to compare the efficacy and safety of applying "PeptiCol EZgraft" in extraction socket preservation procedures against "Regenomer," in terms of reducing the amount of alveolar bone change during the healing process following tooth extraction.
CONDITIONS
Official Title
PeptiCol EZgraft in the Extraction Socket Preservation Process After Tooth Extraction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 19 to 75 years
- Systemically healthy or with mild systemic disease (ASA I or II)
- Planning to place implants in the upper or lower jaw after tooth extraction
- Extraction socket with at least 50% of alveolar bone wall remaining
- Willing to maintain good oral hygiene during the trial
- Voluntarily agree to participate and sign informed consent
- Willing to comply with all trial procedures for the entire duration
You will not qualify if you...
- Extensive alveolar bone loss in the extraction socket area
- Severe gum disease or acute periodontal abscess
- Poor oral hygiene
- History of bone grafts or implants in the treatment area
- Mucosal diseases caused by autoimmune disorders
- Known allergy to collagen products
- Smoking more than 10 cigarettes daily
- Alcohol or drug addiction (screened with AUDIT-K)
- Use of bone-affecting drugs within 2 weeks before screening
- Use of rheumatic or immunosuppressant drugs within 2 weeks before screening
- Long-term use (over 12 weeks) of bisphosphonates for osteoporosis
- Uncontrolled bleeding disorders or use of blood-thinning medications
- Uncontrolled diabetes or high blood pressure
- Significant cardiovascular, gastrointestinal, respiratory, endocrine, or nervous system diseases
- Immune disorders including AIDS
- Pregnant or breastfeeding women
- Participants of childbearing potential must use contraception during the trial and for 16 weeks after
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Dental Hospital
Korea, Seoul, South Korea, 03080
Actively Recruiting
Research Team
P
Park Shin young
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here